NVision is a developer of MRI polarizers and hyperpolarized imaging agents. The company’s hyperpolarization technology permits the assessment of human and animal metabolism by standard MRI, enabling advanced preclinical and clinical applications, including novel cancer diagnosis and monitoring of response to therapy. 2023 delivery of first polarizers to users.
Location: Germany
Employees: 51-200
Total raised: $86.7M
Founded date: 2015
Investors 4
| Date | Name | Website |
| - | Matterwave... | matterwave... |
| - | b2venture | b2venture.... |
| - | Playground... | playground... |
| - | Playground... | playground... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 14.05.2026 | Series B | $55M | Matterwave... |
| 23.06.2023 | Series A | $30M | - |
| 01.01.2022 | Grant | $1.7M | - |
Mentions in press and media 7
| Date | Title | Description |
| 05.06.2026 | 10 millionenschwere Investments, die Lust auf mehr machen | Unser Investmentrückblick auf den Mai 2026: Auch im vergangenen Monat konnten einige Startups, Scaleups und Grownups wieder üppige Millionenbeträge einsammeln. Manche dieser Unternehmen kennt in der Startup-Szene quasi jeder, andere wiederu... |
| 19.05.2026 | NVision Secures $55M, Propelling Quantum Healthcare Beyond Sensing | NVision secured $55 million in Series B funding, totaling $120 million. The quantum technology firm expands from quantum sensing to quantum computing. It targets accelerated drug discovery and validation. Its POLARIS platform enhances MRI f... |
| 14.05.2026 | NVision: $55 Million Series B Raised To Expand From Quantum Sensing Into Quantum Computing For Drug Discovery | NVision announced a $55 million Series B financing round as the company expands from quantum sensing into quantum computing, with the goal of accelerating the discovery and validation of new therapies. The funding round was anchored by Abbo... |
| 13.05.2026 | NVision Raises $55M in Series B Funding | NVision, a Ulm, Germany-based quantum technology company for healthcare, raised $55M Series B financing. The round was led by Abbott, with participation from Playground Global, Matterwave/b2ventures, Entrée Capital, and others. The Series B... |
| 23.06.2023 | NVision Imaging Raises $30M in Series A Funding | NVision Imaging, a Ulm, Germany-based developer of MRI polarizers and hyperpolarized imaging agents, raised $30M in Series A funding, with an additional $19.5M in funding from the German Government. The round, which brought the total amount... |
| 14.02.2023 | Quantum Brilliance snags $18M funding on synthetic diamond road to quantum chips | Quantum Brilliance hit the quantum computing scene in 2019 with an ambitious vision to apply synthetic diamond technology for quantum accelerators. The Australia-based company’s approach is meant to skirt the need for superconducting infras... |
| - | NVision Imaging Technologies | “NVision Imaging Technologies is leveraging advances in quantum physics to enable the first routine, convenient and affordable use of Magnetic Resonance Imaging (MRI) for assessing early patient response to cancer treatment at the metabolic... |